RPP40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.089000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.676000E-01
Normal-vs-Stage2
5.367600E-01
Normal-vs-Stage3
4.851600E-01
Normal-vs-Stage4
8.686100E-02
Stage1-vs-Stage2
4.496000E-01
Stage1-vs-Stage3
7.742000E-01
Stage1-vs-Stage4
4.810600E-01
Stage2-vs-Stage3
7.926600E-01
Stage2-vs-Stage4
1.578170E-01
Stage3-vs-Stage4
3.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.996200E-01
Normal-vs-AfricanAmerican
1.822050E-01
Normal-vs-Asian
9.524200E-01
Caucasian-vs-AfricanAmerican
4.004800E-01
Caucasian-vs-Asian
1.726370E-01
AfricanAmerican-vs-Asian
7.939600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.728800E-01
Normal-vs-Female
4.275600E-01
Male-vs-Female
5.343400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.833200E-01
Normal-vs-Age(41-60Yrs)
3.917200E-01
Normal-vs-Age(61-80Yrs)
6.283200E-01
Normal-vs-Age(81-100Yrs)
2.707000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.934000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.935400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.247600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.346410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.421810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.890600E-01
Normal-vs-Daily Drinker
8.411400E-01
Normal-vs-Weekly Drinker
3.672000E-01
Normal-vs-Occasional Drinker
4.594200E-01
Normal-vs-Social Drinker
5.973000E-01
Non Drinker-vs-Daily Drinker
5.292000E-01
Non Drinker-vs-Weekly Drinker
2.993600E-01
Non Drinker-vs-Occasional Drinker
6.498600E-01
Non Drinker-vs-Social Drinker
9.211200E-01
Daily Drinker-vs-Weekly Drinker
1.701440E-01
Daily Drinker-vs-Occasional Drinker
3.449800E-01
Daily Drinker-vs-Social Drinker
6.516000E-01
Weekly Drinker-vs-Occasional Drinker
5.660000E-01
Weekly Drinker-vs-Social Drinker
3.257800E-01
Occasional Drinker-vs-Social Drinker
6.211400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.828200E-01
Normal-vs-Grade 2
8.776400E-01
Normal-vs-Grade 3
8.709600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.053500E-02
Grade 1-vs-Grade 3
2.504800E-01
Grade 1-vs-Grade 4
7.828200E-01
Grade 2-vs-Grade 3
9.069800E-01
Grade 2-vs-Grade 4
8.776400E-01
Grade 3-vs-Grade 4
8.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.230200E-01
Normal-vs-NonDiabetic
5.439800E-01
Diabetic-vs-NonDiabetic
6.659200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.074600E-01
Normal-vs-NoPancreatitis
5.122400E-01
Pancreatitis-vs-NoPancreatitis
2.635600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.893800E-01
Normal-vs-N1
4.938800E-01
N0-vs-N1
7.530800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.024000E-01
Normal-vs-TP53-NonMutant
5.762000E-01
TP53-Mutant-vs-TP53-NonMutant
2.921000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
